Pharmaceuticals

During my years as a clinical pharmacist, I thought I understood why patients stopped taking long-term medications —…

In LUCENT-2, more than one in four (27.7%) Omvoh-treated patients with ulcerative colitis achieved comprehensive disease control, a…

UnitedHealth Group signage on the floor of the New York Stock Exchange on April 21, 2025. Michael Nagle…

Japan wants pharmaceuticals and advanced medicine to drive its next phase of economic growth. But achieving that goal…

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…

Eli Lilly on Wednesday said its experimental combination regimen resulted in greater weight loss than a high dose…

In TRIUMPH-2, participants with obesity and type 2 diabetes taking retatrutide 12 mg lost an average of 49.6…

People who switched from obesity injections to Novo‘s new Wegovy pill continued to lose weight after three months,…

Two Indian nationals have been charged in federal court in Florida with an alleged conspiracy to smuggle counterfeit…

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…

Novo Nordisk CEO Maziar Mike Doustdar waits for the start of the pharmaceutical company’s annual general meeting in…

Eli Lilly CEO Dave Ricks told CNBC on Monday that 700,000 new seniors have started GLP-1 treatments since…

Why patients stop taking their medications